Selected article for: "FLuc activity and luciferase activity"

Author: Sakata, Masafumi; Tani, Hideki; Anraku, Masaki; Kataoka, Michiyo; Nagata, Noriyo; Seki, Fumio; Tahara, Maino; Otsuki, Noriyuki; Okamoto, Kiyoko; Takeda, Makoto; Mori, Yoshio
Title: Analysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins
  • Document date: 2017_9_14
  • ID: 0xwkte0d_6
    Snippet: In contrast, VSV GFP -RV/CE2E1 infectivity titers remained as low as those of VSV GFP -∆G in immune cell lines, and the infectivity titer, if any, of VSV GFP -RV/CE2E1 could not be detected in most immune cell lines (data not shown). To assess the susceptibility of the immune cell lines to VSV-RV/CE2E1 more sensitively, they were infected with VSV FLuc -RV/CE2E1, and any luciferase activity by the residual VSV FLuc -G was eliminated by the VSV .....
    Document: In contrast, VSV GFP -RV/CE2E1 infectivity titers remained as low as those of VSV GFP -∆G in immune cell lines, and the infectivity titer, if any, of VSV GFP -RV/CE2E1 could not be detected in most immune cell lines (data not shown). To assess the susceptibility of the immune cell lines to VSV-RV/CE2E1 more sensitively, they were infected with VSV FLuc -RV/CE2E1, and any luciferase activity by the residual VSV FLuc -G was eliminated by the VSV G protein-specific antibody (Fig. 4D) . As was expected, the infectivity titers of VSV FLuc -RV/CE2E1 in immune cells were undetectable in many immune cell lines (Fig. 4D ). However, significant, but very low, levels of infectivity titers were detected in THP-1, Jurkat, and MT2 cells (Fig. 4D ).

    Search related documents:
    Co phrase search for related documents
    • cell line and immune cell line: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • cell line and luciferase activity: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • cell line and protein specific antibody: 1, 2
    • immune cell and luciferase activity: 1, 2
    • immune cell and protein specific antibody: 1, 2, 3, 4, 5, 6
    • luciferase activity and protein specific antibody: 1, 2